The incretin enhancer vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed -cell function in patients with type 2 diabetes

Research output: Contribution to journalJournal articleResearch

Standard

The incretin enhancer vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed -cell function in patients with type 2 diabetes. / Mari, A.; Sallas, W.M.; He, Y.L.; Watson, C.; Ligueros-Saylan, M.; Dunning, B.E.; Deacon, Carolyn F.; Holst, Jens Juul; Foley, J.E.

In: Journal of Clinical Endocrinology and Metabolism, No. 90, 2005, p. 4888-4894.

Research output: Contribution to journalJournal articleResearch

Harvard

Mari, A, Sallas, WM, He, YL, Watson, C, Ligueros-Saylan, M, Dunning, BE, Deacon, CF, Holst, JJ & Foley, JE 2005, 'The incretin enhancer vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed -cell function in patients with type 2 diabetes', Journal of Clinical Endocrinology and Metabolism, no. 90, pp. 4888-4894.

APA

Mari, A., Sallas, W. M., He, Y. L., Watson, C., Ligueros-Saylan, M., Dunning, B. E., ... Foley, J. E. (2005). The incretin enhancer vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed -cell function in patients with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, (90), 4888-4894.

Vancouver

Mari A, Sallas WM, He YL, Watson C, Ligueros-Saylan M, Dunning BE et al. The incretin enhancer vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed -cell function in patients with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism. 2005;(90):4888-4894.

Author

Mari, A. ; Sallas, W.M. ; He, Y.L. ; Watson, C. ; Ligueros-Saylan, M. ; Dunning, B.E. ; Deacon, Carolyn F. ; Holst, Jens Juul ; Foley, J.E. / The incretin enhancer vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed -cell function in patients with type 2 diabetes. In: Journal of Clinical Endocrinology and Metabolism. 2005 ; No. 90. pp. 4888-4894.

Bibtex

@article{336de88074c211dbbee902004c4f4f50,
title = "The incretin enhancer vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed -cell function in patients with type 2 diabetes",
author = "A. Mari and W.M. Sallas and Y.L. He and C. Watson and M. Ligueros-Saylan and B.E. Dunning and Deacon, {Carolyn F.} and Holst, {Jens Juul} and J.E. Foley",
year = "2005",
language = "English",
pages = "4888--4894",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "Oxford University Press",
number = "90",

}

RIS

TY - JOUR

T1 - The incretin enhancer vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed -cell function in patients with type 2 diabetes

AU - Mari, A.

AU - Sallas, W.M.

AU - He, Y.L.

AU - Watson, C.

AU - Ligueros-Saylan, M.

AU - Dunning, B.E.

AU - Deacon, Carolyn F.

AU - Holst, Jens Juul

AU - Foley, J.E.

PY - 2005

Y1 - 2005

M3 - Journal article

SP - 4888

EP - 4894

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 90

ER -

ID: 70520